These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 37838974)

  • 21. KDM5A and KDM5B histone-demethylases contribute to HU-induced replication stress response and tolerance.
    Gaillard S; Charasson V; Ribeyre C; Salifou K; Pillaire MJ; Hoffmann JS; Constantinou A; Trouche D; Vandromme M
    Biol Open; 2021 May; 10(5):. PubMed ID: 34184733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human papillomavirus type 16 E7 oncoprotein-induced upregulation of lysine-specific demethylase 5A promotes cervical cancer progression by regulating the microRNA-424-5p/suppressor of zeste 12 pathway.
    Liu J; Zhao H; Zhang Q; Shi Z; Zhang Y; Zhao L; Ren Y; Ou R; Xu Y
    Exp Cell Res; 2020 Nov; 396(1):112277. PubMed ID: 32918895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potent and Selective KDM5 Inhibitor Stops Cellular Demethylation of H3K4me3 at Transcription Start Sites and Proliferation of MM1S Myeloma Cells.
    Tumber A; Nuzzi A; Hookway ES; Hatch SB; Velupillai S; Johansson C; Kawamura A; Savitsky P; Yapp C; Szykowska A; Wu N; Bountra C; Strain-Damerell C; Burgess-Brown NA; Ruda GF; Fedorov O; Munro S; England KS; Nowak RP; Schofield CJ; La Thangue NB; Pawlyn C; Davies F; Morgan G; Athanasou N; Müller S; Oppermann U; Brennan PE
    Cell Chem Biol; 2017 Mar; 24(3):371-380. PubMed ID: 28262558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histone demethylase KDM5A inhibits glioma cells migration and invasion by down regulating ZEB1.
    Dai B; Huang H; Guan F; Zhu G; Xiao Z; Mao B; Su H; Hu Z
    Biomed Pharmacother; 2018 Mar; 99():72-80. PubMed ID: 29324315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting histone demethylases KDM5A and KDM5B in AML cancer cells: A comparative view.
    Shokri G; Doudi S; Fathi-Roudsari M; Kouhkan F; Sanati MH
    Leuk Res; 2018 May; 68():105-111. PubMed ID: 29602065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KDM5A controls bone morphogenic protein 2-induced osteogenic differentiation of bone mesenchymal stem cells during osteoporosis.
    Wang C; Wang J; Li J; Hu G; Shan S; Li Q; Zhang X
    Cell Death Dis; 2016 Aug; 7(8):e2335. PubMed ID: 27512956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disruption of the autism gene and chromatin regulator KDM5A alters hippocampal cell identity.
    El Hayek L; DeVries D; Gogate A; Aiken A; Kaur K; Chahrour MH
    Sci Adv; 2023 Nov; 9(47):eadi0074. PubMed ID: 37992166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective targeting of histone methylation.
    Islam AB; Richter WF; Lopez-Bigas N; Benevolenskaya EV
    Cell Cycle; 2011 Feb; 10(3):413-24. PubMed ID: 21270517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The KDM5A/RBP2 histone demethylase represses NOTCH signaling to sustain neuroendocrine differentiation and promote small cell lung cancer tumorigenesis.
    Oser MG; Sabet AH; Gao W; Chakraborty AA; Schinzel AC; Jennings RB; Fonseca R; Bonal DM; Booker MA; Flaifel A; Novak JS; Christensen CL; Zhang H; Herbert ZT; Tolstorukov MY; Buss EJ; Wong KK; Bronson RT; Nguyen QD; Signoretti S; Kaelin WG
    Genes Dev; 2019 Dec; 33(23-24):1718-1738. PubMed ID: 31727771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissecting contributions of catalytic and reader domains in regulation of histone demethylation.
    Petronikolou N; Longbotham JE; Fujimori DG
    Methods Enzymol; 2020; 639():217-236. PubMed ID: 32475402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic amplification and a role in drug-resistance for the KDM5A histone demethylase in breast cancer.
    Hou J; Wu J; Dombkowski A; Zhang K; Holowatyj A; Boerner JL; Yang ZQ
    Am J Transl Res; 2012; 4(3):247-56. PubMed ID: 22937203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histone H3K4 demethylases are essential in development and differentiation.
    Benevolenskaya EV
    Biochem Cell Biol; 2007 Aug; 85(4):435-43. PubMed ID: 17713579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histone H3 binding to the PHD1 domain of histone demethylase KDM5A enables active site remodeling.
    Longbotham JE; Chio CM; Dharmarajan V; Trnka MJ; Torres IO; Goswami D; Ruiz K; Burlingame AL; Griffin PR; Fujimori DG
    Nat Commun; 2019 Jan; 10(1):94. PubMed ID: 30626866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional activation by pRB and its coordination with SWI/SNF recruitment.
    Flowers S; Beck GR; Moran E
    Cancer Res; 2010 Nov; 70(21):8282-7. PubMed ID: 20851996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxia induces rapid changes to histone methylation and reprograms chromatin.
    Batie M; Frost J; Frost M; Wilson JW; Schofield P; Rocha S
    Science; 2019 Mar; 363(6432):1222-1226. PubMed ID: 30872526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recognition of Histone H3 Methylation States by the PHD1 Domain of Histone Demethylase KDM5A.
    Longbotham JE; Kelly MJS; Fujimori DG
    ACS Chem Biol; 2023 Sep; 18(9):1915-1925. PubMed ID: 33621062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of in vitro JMJD lysine demethylase candidate substrates via systematic determination of substrate preference.
    Hoekstra M; Biggar KK
    Anal Biochem; 2021 Nov; 633():114429. PubMed ID: 34678252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KDM5 lysine demethylases are involved in maintenance of 3'UTR length.
    Blair LP; Liu Z; Labitigan RL; Wu L; Zheng D; Xia Z; Pearson EL; Nazeer FI; Cao J; Lang SM; Rines RJ; Mackintosh SG; Moore CL; Li W; Tian B; Tackett AJ; Yan Q
    Sci Adv; 2016 Nov; 2(11):e1501662. PubMed ID: 28138513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screen-identified selective inhibitor of lysine demethylase 5A blocks cancer cell growth and drug resistance.
    Gale M; Sayegh J; Cao J; Norcia M; Gareiss P; Hoyer D; Merkel JS; Yan Q
    Oncotarget; 2016 Jun; 7(26):39931-39944. PubMed ID: 27224921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. H3K4me3 Demethylase Kdm5a Is Required for NK Cell Activation by Associating with p50 to Suppress SOCS1.
    Zhao D; Zhang Q; Liu Y; Li X; Zhao K; Ding Y; Li Z; Shen Q; Wang C; Li N; Cao X
    Cell Rep; 2016 Apr; 15(2):288-99. PubMed ID: 27050510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.